NASDAQ:CGIX
Delisted
Cancer Genetics Stock News
$1.08
+0 (+0%)
At Close: May 27, 2022
Mid-Morning Market Update: Markets Open Lower; Hostess Brands To Buy Voortman Cookies
12:00am, Monday, 02'nd Dec 2019Cancer Genetics Reports Third Quarter 2019 Financial Results and Provides Strategic Business Update
01:00pm, Wednesday, 20'th Nov 2019
RUTHERFORD, N.J., Nov. 20, 2019 -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in drug discovery and preclinical oncology and immuno-oncology services, today announced.
Options Traders Pile on Sinking Chinese Stock - Schaeffer's Investment Research
07:44am, Wednesday, 20'th Nov 2019
Options traders blast Pinduoduo (PDD) and AT&T (T) stocks, while Cancer Genetics scales the Nasdaq